scholarly journals Development and Validation of a Customer Satisfaction Measuring Instrument with Laboratory Services at the University Hospital of Kinshasa, Democratic Republic of the Congo (DRC)

2021 ◽  
Vol 11 (05) ◽  
pp. 481-498
Author(s):  
Chabo Byaene Alain ◽  
Mabela Makengo Matendo Rostin ◽  
Konde Nkiama Numbi Joël ◽  
Muhindo Mavoko Hypolite ◽  
Kayembe Nzongola-Nkasu Donatien ◽  
...  
2021 ◽  
Vol 9 (1) ◽  
pp. 44-50
Author(s):  
Chabo Byaene Alain ◽  
◽  
Mabela Matendo Rostin ◽  
Konde Numbi Joël ◽  
Muhindo Mavoko Hypolite ◽  
...  

The evaluation of the quality of a service is the critical assessment of the degree to which the service, or its component, provides customers’ satisfaction. Monitoring customer satisfaction is an important and useful quality improvement tool for clinical laboratories and health care organizations. The purpose of this research is to evaluate the satisfaction level with laboratory services among attending physicians and to identify factors associated with satisfaction and priorities for quality improvement. A cross-sectional study was conducted at the University Hospital of Kinshasa. Data were collected through a reliable and valid interviewer-administered questionnaire and analyzed by using SPSS version 21. The correlation between associated factors and customer satisfaction was analyzed using the chi-square test and multivariate regression analysis. The Importance-Performance Analysis was the determinant of improvement priority. The overall level of customers’ satisfaction toward clinical laboratory services in this study was 45.2% with a response rate of 330 (100%). Gender (ORadj = 1.75, 95% CI 1.06, 2.91), Department (ORadj = 3.09, 95% CI 1.50, 6.37) and academic title (ORadj = 6.85, 95% CI 3.51, 8.81) were found to have a statistically significant association with the overall satisfaction. Results accuracy (I = 0.944, P = 4.7), laboratory turnaround time (I = 0.932, P = 4.8), and availability of all the tests requested by physicians (I = 0.917, P = 4.9) were the most important opportunities for quality improvement. The overall level of customers’ satisfaction with laboratory services was low. Thus, the laboratory management must establish preventive and corrective measures to improve the results’ accuracy, reduce the laboratory turnaround time, and ensure the availability of all the tests requested by physicians. Keywords: Customers satisfaction, clinical laboratory, services’ quality, continuous improvement, Democratic Republic of the Congo.


2021 ◽  
Vol 9 (1) ◽  
pp. 35-43
Author(s):  
Chabo Byaene Alain ◽  
◽  
Mabela Matendo Rostin ◽  
Konde Numbi Joël ◽  
Muhindo Mavoko Hypolite ◽  
...  

The customer satisfaction-customer loyalty association is one of the most vital relationships for marketing theory and practice. However, there is a lack of consensus in the literature and among researchers about the causal link between the two concepts. The purpose of this research is to determine the strength and direction of the relationship between customer satisfaction and customer loyalty in a clinical laboratory. This study proposes a mathematical model examining the relationship among two variables: customer satisfaction and customer loyalty. It is based on the survey data collected from 330 attending physicians in the University Hospital of Kinshasa. The chi-square test of independence and linear regression analysis techniques are used to investigate the relationship between the two variables. The key findings of the study indicate that customer satisfaction and customer loyalty are related (χ2 = 226.978, df = 1, p < 0.001). There is a strong positive significant linear relationship between the two variables (r = 0.892, N = 330, p < 0.001). The R2 value of 0.795 reveals that customer satisfaction accounts for 79.5% of the variation in customer loyalty. The mean customer loyalty value increases by 0.945 for every one unit change in customer satisfaction (loyalty = 0.945satisfaction + 0.347). Customer loyalty is a function of customer satisfaction. Laboratory management should concentrate on customer satisfaction to improve customer loyalty and, thus, assure laboratory survival in the current competitive environment. Keywords: Customers’ satisfaction, clinical laboratory, Democratic Republic of the Congo, Customers’ loyalty.


2020 ◽  
Vol 37 ◽  
Author(s):  
Ben Izizag Bepouka ◽  
Madone Mandina ◽  
Jean Robert Makulo ◽  
Murielle Longokolo ◽  
Ossam Odio ◽  
...  

2013 ◽  
Vol 59 (4) ◽  
pp. 274-279 ◽  
Author(s):  
T. Biselele ◽  
G. Naulaers ◽  
P. Bunga Muntu ◽  
E. Nkidiaka ◽  
M. Kapepela ◽  
...  

2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 1644-1645
Author(s):  
P. Lebughe ◽  
K. De Vlam ◽  
R. Westhovens ◽  
J. M. Mbuyi-Muamba ◽  
J. J. Malemba

Background:Inflammatory back pain (IBP) is the most prominent clinical feature for an early diagnosis of axial spondyloarthritis. The performance of the criteria sets for IBP has not yet been assessed in clinical practice in the Democratic Republic of Congo (DRC).Objectives:To assess and to compare the performance of different IBP criteria sets in axial spondyloarthritis (SpA) outpatients attending the rheumatology unit of the University Hospital of Kinshasa, DRC.Methods:One hundred and eight Congolese outpatients with axial SpA defined by rheumatologist’s clinical judgment were included in the spondyloarthritis cohort of the University Hospital of Kinshasa from March 1st2015 to February 28, 2017. Calin criteria, Berlin criteria and ASAS criteria sets for IBP were performed to assess their performance against clinical judgment. Detailed history, clinical examination and imaging of sacroiliac joints by plain radiography were obtained. Sacroiliac joint radiographic lesions were scored with the modified New York criteria. Magnetic resonance imaging and HLA B27 were not performed. Fifty additional patients with a diagnosis of chronic (>3 months) mechanical low back pain (MLBP) were included as control group. The performance of each item and different criterias was evaluated using sensitivity, specificity, and likelihood ratio (LR). Baseline characteristics of the mechanical and inflammatory back pain cohorts were compared with chi-square or Student t tests as appropriate.Results:The mean age was 43.8±15.1 years in SpA patients versus 62.4±9.1 years in controls (MLBP patients) with respective sex ratio (M/F) of 1/0.8 and 1/2.1. There were significantly more male patients in the ankylosing spondylitis (AS) group than in the non-radiographic axial spondyloarthritis group (p<0.01). Among the criteria sets, Calin criteria showed the best sensitivity (92.6%) while the Berlin criteria showed the best specificity (97.6%) in the detection of IBP patients. The new ASAS criteria for IBP compared to the two previous criteria sets did not show good sensitivity nor specificity (sensivity 80%, specificity 62%, LR+ 1.05 (0.90 – 1.22), LR- 0.52 (0.39 – 0.69), 95%CI).Conclusion:The Calin criteria set would be useful for epidemiological and clinical studies in DRC. The ASAS criteria set for IBP is not better than other criteria sets in the screening of IBP for Congolese patients with axSpA.References:[1]Heuft-Dorenbosch L, Landewe R, Weijers R et al.Performance of various criteria sets in patients with inflammatory back pain of short duration; the Maastricht early spondyloarthritis clinic Ann Rheum Dis 2007;66:92–98. doi: 10.1136/ard.2006.053918[2]Michele C. Battié M, LINDA J. CARROLL et al. Preliminary Validation of a Self-reported Screening Questionnaire for Inflammatory Back Pain. J Rheumatol 2012;39;822-829[3]Poddubnyy D, Callhoff J, Spiller I, et al. Diagnostic accuracy of inflammatory back pain for axial spondyloarthritis in rheumatological care.RMD Open. 2018;4(2):e000825. Published 2018 Dec 5. doi:10.1136/rmdopen-2018-000825[4]Wang R, Crowson CS, Wright K, Ward MM. Clinical Evolution in Patients With New-Onset Inflammatory Back Pain: A Population-Based Cohort Study.Arthritis Rheumatol. 2018;70(7):1049–1055. doi:10.1002/art.40460Disclosure of Interests:Pierrot Lebughe: None declared, Kurt de Vlam Grant/research support from: Celgene, Eli Lilly, Pfizer Inc, Consultant of: AbbVie, Eli Lilly, Galapagos, Johnson & Johnson, Novartis, Pfizer Inc, UCB, Rene Westhovens Grant/research support from: Celltrion Inc, Galapagos, Gilead, Consultant of: Celltrion Inc, Galapagos, Gilead, Speakers bureau: Celltrion Inc, Galapagos, Gilead, Jean-Marie Mbuyi-Muamba: None declared, Jean-Jacques Malemba: None declared


2021 ◽  
Author(s):  
Trésor Zola Matuvanga ◽  
Ginger Johnson ◽  
Ynke Larivière ◽  
Emmanuel Esanga ◽  
Junior Matangila-Rika ◽  
...  

BACKGROUND As part of an Ebola outbreak preparedness initiative, a partnership between the University of Antwerp and the University of Kinshasa, through an Innovative Medicines Initiative-European Union (project ‘EBOVAC 3’), implemented a clinical trial on an Ebola vaccine regimen to be administered to health care provider participants (HCP-P) in Tshuapa Province (Democratic Republic of the Congo). The EBOVAC3 clinical trial used iris scan technology to identify all HCP-P participating in the vaccine trial so the right participant received the right vaccine at the right visit. OBJECTIVE To assess the acceptability, accuracy and feasibility of iris scan technology as an identification method within a population of HCP-P in a vaccine trial in a remote setting. METHODS A mixed-method study was utilized. The acceptability was assessed prior to the trial through 12 focus group discussions (FGDs) and assessed at enrolment. Feasibility and accuracy research was conducted using a longitudinal trial study design where iris scanning was compared to the unique study ID card to identify HCP-P at enrolment, and at their follow-up visits. RESULTS During the FGDs, main concerns raised by HCP-P about the iris scan technology were that it may cause physical problems to their eyes or expose them to spiritual problems through sorcery. Though, 99.1% (95%CI: 97.1;100.0) of HCP-P in the FGDs agreed to be identified by the iris scan. Also, at enrolment 99.0% (95%CI:98.3; 99.7) HCP-P accepted to be identified by iris scan. Iris scan technology correctly identified 93.1% (95%CI:91.2; 95.0) of the participants returning for scheduled follow-up visits. Iris scanning operation lasted no more than 2 minutes 30 seconds for 96.0% (95%CI: 99.0;100.0) and one attempt was enough to identify the majority of study volunteers [69.5% (95% CI:66.1;73.0)]. CONCLUSIONS Iris scan is highly acceptable as an identification tool in a clinical trial in HCP-Ps. Its operationalization during the trial demonstrated a high-level of accuracy that can reliably identify individuals. Iris scanning is found to be feasible in clinical trials but it requires a trained operator in order to reduce the duration and the number of attempts to identify a participant.


2018 ◽  
Vol 06 (03) ◽  
Author(s):  
Katabwa Kabongo Joe ◽  
Junior Tavele ◽  
Wembonyama S ◽  
Mutombo Valerien ◽  
Mukendi R

2021 ◽  
Vol 09 (02) ◽  
pp. 12-20
Author(s):  
Ben Bepouka ◽  
Hippolyte Situakibanza ◽  
Ossam Odio ◽  
Jean Robert Makulo ◽  
Madone Mandina ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-5 ◽  
Author(s):  
Aimé Kazadi Lukusa ◽  
Michel Ntetani Aloni ◽  
Bertin Kadima-Tshimanga ◽  
Moïse Mvitu-Muaka ◽  
Jean Lambert Gini Ehungu ◽  
...  

Background.To determine clinical profile and management of retinoblastoma among children at Kinshasa in Democratic Republic of Congo.Patients and methods. The medical records of patients with a diagnosis of retinoblastoma seen at the University Hospital of Kinshasa from January 1985 till December 2005 were retrospectively reviewed. Demographic profile, clinical data, modes of treatment and outcome were analysed.Results. A total of 49 children, of whom 40 had adequate data on record were identified as retinoblastoma (28 males and 12 females). Nine cases had bilateral disease. The median age at the first symptoms was 9 months (range, 1 month to 6 years) for unilateral retinoblastoma and 18 months (range, 1 month to 3.5 years) for bilateral retinoblastoma. The median age at the first oncology consultation was 2.4 years (range, 6 months to 6 years) for unilateral retinoblastoma and 2.4years (range, 9 months to 4 years) for bilateral disease. Leukokoria was present in 67.5% of subjects. Seventy-five percent abandoned the treatment. The mortality was 92.5%.Conclusion. In Democratic Republic of Congo, retinoblastoma remains a life threatening disease characterized by late referral to a specialized unit and affordability of chemotherapy; all leading to an extension of the disease and high mortality.


Sign in / Sign up

Export Citation Format

Share Document